Clinical Trial Update: Malaria Candidate Vaccines FP9 Circumsporozoite (CS) and MVA CS in Adult Gambian Men [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial evaluates two malaria vaccine candidates, FP9 Circumsporozoite (CS) and MVA CS, in adult Gambian men. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• FP9 Circumsporozoite Vaccine (Circumsporozoite vaccine FP9)
• MVA CS Vaccine (Circumsporozoite vaccine MVA CS)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 1 | Status: COMPLETED